Continuous Flow Reactor

在过去的50年里，提高人类生活质量和寿命的药物活性剂的发展对社会产生了巨大的影响。然而，由于临床候选药物在药物开发各个阶段的低成功率（<0.2%），药物发现的成本不断增加，促使人们对导致高失败率的因素进行了认真的分析。例如，推销一种新药的平均成本超过10亿美元，其中只有十分之三的药物产生足够的收入来支付研发成本。

The development of pharmacologically active agents that improve the quality and longevity of human life has had an enormous societal impact over the last 50 years. Nevertheless, the increasing cost of drug discovery, due to the low success rate of clinical candidates progressing through the various phases of drug development (<0.2%), has prompted serious analysis of the factors that contribute to the high failure rate. For example, the average cost to market a new drug is in excess of $1 billion, in which only three out of ten drugs generate enough revenue to cover the costs of the research and development.